Canine Stem Cell Therapy

Abstract:

Global Canine Stem Cell Therapy Market to Reach $212.7 Million by 2027

Amid the COVID-19 crisis, the global market for Canine Stem Cell Therapy estimated at US$161.7 Million in the year 2020, is projected to reach a revised size of US$212.7 Million by 2027, growing at aCAGR of 4% over the period 2020-2027. Allogeneic Stem Cells, one of the segments analyzed in the report, is projected to record 4.5% CAGR and reach US$146.9 Million by the end of the analysis period. After an early analysis of the business implications of the pandemic and its induced economic crisis, growth in the Autologous Stem Cells segment is readjusted to a revised 3% CAGR for the next 7-year period.

The U.S. Market is Estimated at $47.6 Million, While China is Forecast to Grow at 3.8% CAGR

The Canine Stem Cell Therapy market in the U.S. is estimated at US$47.6 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$37.8 Million by the year 2027 trailing a CAGR of 3.8% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 3.7% and 3.3% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.8% CAGR.

Select Competitors (Total 47 Featured) -

• Animal Cell Therapies, Inc
• Aratana Therapeutics, Inc.
• Cell Therapy Sciences
• Magellan Stem Cells
• MediVet Biologics, LLC
• Okyanos
• Regeneus Ltd.
• Stem Cell Vet
• Vetbiologics
• VetMatrix

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • World Market Trajectories
  • Impact of Covid-19 and a Looming Global Recession
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Current & Future Analysis for Canine Stem Cell Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
  • TABLE 2: World Historic Review for Canine Stem Cell Therapy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • TABLE 3: World 15-Year Perspective for Canine Stem Cell Therapy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2012, 2020 & 2027
  • TABLE 4: World Current & Future Analysis for Allogeneic Stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
  • TABLE 5: World Historic Review for Allogeneic Stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • TABLE 6: World 15-Year Perspective for Allogeneic Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • TABLE 7: World Current & Future Analysis for Autologous Stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
  • TABLE 8: World Historic Review for Autologous Stem Cells by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • TABLE 9: World 15-Year Perspective for Autologous Stem Cells by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • TABLE 10: World Current & Future Analysis for Veterinary Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
  • TABLE 11: World Historic Review for Veterinary Hospitals by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • TABLE 12: World 15-Year Perspective for Veterinary Hospitals by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • TABLE 13: World Current & Future Analysis for Veterinary Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
  • TABLE 14: World Historic Review for Veterinary Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • TABLE 15: World 15-Year Perspective for Veterinary Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027
  • TABLE 16: World Current & Future Analysis for Veterinary Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
  • TABLE 17: World Historic Review for Veterinary Research Institutes by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • TABLE 18: World 15-Year Perspective for Veterinary Research Institutes by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2012, 2020 & 2027

III. MARKET ANALYSIS

• UNITED STATES
  • TABLE 19: USA Current & Future Analysis for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • TABLE 20: USA Historic Review for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • TABLE 21: USA 15-Year Perspective for Canine Stem Cell Therapy by Type - Percentage Breakdown of Value Sales for Allogeneic Stem Cells and Autologous Stem Cells for the Years 2012, 2020 & 2027
  • TABLE 22: USA Current & Future Analysis for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • TABLE 23: USA Historic Review for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • TABLE 24: USA 15-Year Perspective for Canine Stem Cell Therapy by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes for the Years 2012, 2020 & 2027
• CANADA
  • TABLE 25: Canada Current & Future Analysis for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • TABLE 26: Canada Historic Review for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • TABLE 27: Canada 15-Year Perspective for Canine Stem Cell Therapy by Type - Percentage Breakdown of Value Sales for Allogeneic Stem Cells and Autologous Stem Cells for the Years 2012, 2020 & 2027
  • TABLE 28: Canada Current & Future Analysis for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • TABLE 29: Canada Historic Review for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • TABLE 30: Canada 15-Year Perspective for Canine Stem Cell Therapy by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes for the Years 2012, 2020 & 2027
• JAPAN
  • TABLE 31: Japan Current & Future Analysis for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • TABLE 32: Japan Historic Review for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • TABLE 33: Japan 15-Year Perspective for Canine Stem Cell Therapy by Type - Percentage Breakdown of Value Sales for Allogeneic Stem Cells and Autologous Stem Cells for the Years 2012, 2020 & 2027
  • TABLE 34: Japan Current & Future Analysis for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • TABLE 35: Japan Historic Review for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • TABLE 36: Japan 15-Year Perspective for Canine Stem Cell Therapy by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes for the Years 2012, 2020 & 2027
• CHINA
  • TABLE 37: China Current & Future Analysis for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • TABLE 38: China Historic Review for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • TABLE 39: China 15-Year Perspective for Canine Stem Cell Therapy by Type - Percentage Breakdown of Value Sales for Allogeneic Stem Cells and Autologous Stem Cells for the Years 2012, 2020 & 2027
  • TABLE 40: China Current & Future Analysis for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • TABLE 41: China Historic Review for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • TABLE 42: China 15-Year Perspective for Canine Stem Cell Therapy by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes for the Years 2012, 2020 & 2027
• EUROPE
  • TABLE 43: Europe Current & Future Analysis for Canine Stem Cell Therapy by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2020 through 2027 and % CAGR
  • TABLE 44: Europe Historic Review for Canine Stem Cell Therapy by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • TABLE 45: Europe 15-Year Perspective for Canine Stem Cell Therapy by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2012, 2020 & 2027
  • TABLE 46: Europe Current & Future Analysis for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • TABLE 47: Europe Historic Review for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • TABLE 48: Europe 15-Year Perspective for Canine Stem Cell Therapy by Type - Percentage Breakdown of Value Sales for Allogeneic Stem Cells and Autologous Stem Cells for the Years 2012, 2020 & 2027
  • TABLE 49: Europe Current & Future Analysis for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • TABLE 50: Europe Historic Review for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • TABLE 51: Europe 15-Year Perspective for Canine Stem Cell Therapy by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes for the Years 2012, 2020 & 2027
• FRANCE
  • TABLE 52: France Current & Future Analysis for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • TABLE 53: France Historic Review for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • TABLE 54: France 15-Year Perspective for Canine Stem Cell Therapy by Type - Percentage Breakdown of Value Sales for Allogeneic Stem Cells and Autologous Stem Cells for the Years 2012, 2020 & 2027
  • TABLE 55: France Current & Future Analysis for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • TABLE 56: France Historic Review for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • TABLE 57: France 15-Year Perspective for Canine Stem Cell Therapy by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes for the Years 2012, 2020 & 2027
• GERMANY
  • TABLE 58: Germany Current & Future Analysis for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • TABLE 59: Germany Historic Review for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • TABLE 60: Germany 15-Year Perspective for Canine Stem Cell Therapy by Type - Percentage Breakdown of Value Sales for Allogeneic Stem Cells and Autologous Stem Cells for the Years 2012, 2020 & 2027
  • TABLE 61: Germany Current & Future Analysis for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • TABLE 62: Germany Historic Review for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • TABLE 63: Germany 15-Year Perspective for Canine Stem Cell Therapy by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes for the Years 2012, 2020 & 2027
• ITALY
  • TABLE 64: Italy Current & Future Analysis for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • TABLE 65: Italy Historic Review for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • TABLE 66: Italy 15-Year Perspective for Canine Stem Cell Therapy by Type - Percentage Breakdown of Value Sales for Allogeneic Stem Cells and Autologous Stem Cells for the Years 2012, 2020 & 2027
  • TABLE 67: Italy Current & Future Analysis for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • TABLE 68: Italy Historic Review for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • TABLE 69: Italy 15-Year Perspective for Canine Stem Cell Therapy by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes for the Years 2012, 2020 & 2027
• UNITED KINGDOM
  • TABLE 70: UK Current & Future Analysis for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • TABLE 71: UK Historic Review for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • TABLE 72: UK 15-Year Perspective for Canine Stem Cell Therapy by Type - Percentage Breakdown of Value Sales for Allogeneic Stem Cells and Autologous Stem Cells for the Years 2012, 2020 & 2027
  • TABLE 73: UK Current & Future Analysis for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • TABLE 74: UK Historic Review for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • TABLE 75: UK 15-Year Perspective for Canine Stem Cell Therapy by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes for the Years 2012, 2020 & 2027
• REST OF EUROPE
  • TABLE 76: Rest of Europe Current & Future Analysis for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • TABLE 77: Rest of Europe Historic Review for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • TABLE 78: Rest of Europe 15-Year Perspective for Canine Stem Cell Therapy by Type - Percentage Breakdown of Value Sales for Allogeneic Stem Cells and Autologous Stem Cells for the Years 2012, 2020 & 2027
  • TABLE 79: Rest of Europe Current & Future Analysis for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • TABLE 80: Rest of Europe Historic Review for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • TABLE 81: Rest of Europe 15-Year Perspective for Canine Stem Cell Therapy by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes for the Years 2012, 2020 & 2027
• ASIA-PACIFIC
  • TABLE 82: Asia-Pacific Current & Future Analysis for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • TABLE 83: Asia-Pacific Historic Review for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • TABLE 84: Asia-Pacific 15-Year Perspective for Canine Stem Cell Therapy by Type - Percentage Breakdown of Value Sales for Allogeneic Stem Cells and Autologous Stem Cells for the Years 2012, 2020 & 2027
  • TABLE 85: Asia-Pacific Current & Future Analysis for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • TABLE 86: Asia-Pacific Historic Review for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • TABLE 87: Asia-Pacific 15-Year Perspective for Canine Stem Cell Therapy by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes for the Years 2012, 2020 & 2027
• REST OF WORLD
  • TABLE 88: Rest of World Current & Future Analysis for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • TABLE 89: Rest of World Historic Review for Canine Stem Cell Therapy by Type - Allogeneic Stem Cells and Autologous Stem Cells Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • TABLE 90: Rest of World 15-Year Perspective for Canine Stem Cell Therapy by Type - Percentage Breakdown of Value Sales for Allogeneic Stem Cells and Autologous Stem Cells for the Years 2012, 2020 & 2027
  • TABLE 91: Rest of World Current & Future Analysis for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes - Independent Analysis of Annual Sales in US$ for the Years 2020 through 2027 and % CAGR
  • TABLE 92: Rest of World Historic Review for Canine Stem Cell Therapy by End-Use - Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes Markets - Independent Analysis of Annual Sales in US$ for Years 2012 through 2019 and % CAGR
  • TABLE 93: Rest of World 15-Year Perspective for Canine Stem Cell Therapy by End-Use - Percentage Breakdown of Value Sales for Veterinary Hospitals, Veterinary Clinics and Veterinary Research Institutes for the Years 2012, 2020 & 2027

IV. COMPETITION

• Total Companies Profiled: 47